CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-16 00:00 |
신탁계약해지결과보고서
|
Korean | 19.6 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | 2.3 MB | ||
| 2022-03-29 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 2.9 MB | ||
| 2022-03-28 00:00 |
정기주주총회결과
|
Korean | 19.8 KB | ||
| 2022-03-21 00:00 |
투자판단관련주요경영사항(신종코로나-19 바이러스 감염이 확진된 입원을 요하는 중등증 및 중증 COVID-19 환자에서 Ivaltinostat …
|
Korean | 10.0 KB | ||
| 2022-03-18 00:00 |
감사보고서제출
|
Korean | 25.3 KB | ||
| 2022-03-18 00:00 |
사업보고서 (2021.12)
|
Korean | 701.9 KB | ||
| 2022-03-14 00:00 |
주주총회소집공고
|
Korean | 136.8 KB | ||
| 2022-03-14 00:00 |
의결권대리행사권유참고서류
|
Korean | 119.8 KB | ||
| 2022-03-11 00:00 |
주식매수선택권부여에관한신고
|
Korean | 36.9 KB | ||
| 2022-03-11 00:00 |
주주총회소집결의
|
Korean | 9.0 KB | ||
| 2022-03-03 00:00 |
투자판단관련주요경영사항(수술이 불가능한 진행성 또는 전이성 췌장암 환자에서 Ivaltinostat/Gemcitabine/Erlotinib병용요…
|
Korean | 9.4 KB | ||
| 2022-03-02 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2022-02-25 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.6 KB | ||
| 2022-02-15 00:00 |
투자판단관련주요경영사항
|
Korean | 11.4 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
